multiple sclerosis

Experts are weighing what precision medicine should actually mean for multiple sclerosis care, moving beyond the label toward individualized treatment selection based on disease biology, biomarkers and patient characteristics. The discussion reflects a broader push in neurology to tailor disease-modifying therapies rather than rely on a one-size-fits-all approach, though consensus on a clear definition and clinical implementation remains limited.